I have always thought this stock was a dog and was curious why anyone in their right mind would be buying especially Bell IXL who appears to have a real appeitite for the stock.
I've done a quick calculation on the value of LFE post approval of the Octapharma transaction which values the company well above the current market price.
You'd have to think that most shareholder will support the sale to Octapharma given the significant value improvement it delivers.
Maybe Bell IXL is not that silly after all...
- Forums
- ASX - By Stock
- LFE
- way undervalued
LFE
life therapeutics limited
way undervalued
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.